Advertisement
CL vs KVUE
Which Stock Would AI Choose? Colgate-Palmolive (CL) vs. Kenvue (KVUE) Stock Comparison
Key Takeaways
- CL is a diversified consumer-staples giant spanning oral care, personal and home care, and Hill's Pet Nutrition, while KVUE is the world's largest pure-play consumer-health company.
- Colgate-Palmolive is delivering stronger organic growth driven by emerging markets, whereas Kenvue's fundamentals are now largely anchored to its pending acquisition by Kimberly-Clark.
- CL trades at a premium valuation with very low volatility, while KVUE trades near its takeover-implied value with a higher dividend yield.
- Both names face execution risks: North America softness for Colgate-Palmolive and litigation plus deal-closing uncertainty for Kenvue.
- For more detail on breaking developments and intraday activity, explore CL Major News and CL Today's Price Move, as well as KVUE Major News and KVUE Today's Price Move.
- To see how automated strategies are positioning across these and other tickers, visit the Trending AI Robots page.
Introduction
Consumer staples and consumer health are often grouped together as "defensive" sectors, yet CL (Colgate-Palmolive) and KVUE (Kenvue) offer very different risk-reward profiles in the current market. Colgate-Palmolive is a globally diversified oral-care and pet-nutrition leader, while Kenvue is a consumer-health portfolio in the process of being acquired by Kimberly-Clark. This comparison is most relevant to investors weighing steady, brand-driven growth against a company whose near-term path is defined by a merger. Income-oriented and defensive-minded traders, as well as those evaluating sector rotation, may find the relative performance and market positioning of these two names instructive.
CL Overview and Recent Performance
Colgate-Palmolive operates across oral care, personal care, home care, and Hill's Pet Nutrition, giving it one of the broadest consumer-staples footprints in the market. In recent quarters, the company has reported solid top-line momentum, with second-quarter revenue rising about 4.9% year over year to roughly $5.36 billion and gross margin expanding as pricing, favorable mix, and productivity gains offset higher raw-material and tariff costs. Emerging markets—led by India, Brazil, Mexico, and China—have been the primary growth engine, while North America has remained the clearest soft spot.
From a market perspective, CL has benefited from a rotation toward defensive names, and its very low beta (a measure of sensitivity to broader market moves) has reinforced that appeal. The stock has eased somewhat in recent weeks after a strong run and trades at a premium forward price-to-earnings (P/E) multiple relative to peers, which leaves less room for execution missteps. A recently announced leadership change in its India unit and persistent North American volume pressure are among the factors investors are watching ahead of upcoming results.
KVUE Overview and Recent Performance
Kenvue is the world's largest pure-play consumer-health company, holding brands such as Tylenol, Neutrogena, Listerine, and Band-Aid across its Self Care, Skin Health and Beauty, and Essential Health segments. Its operating story has been mixed: first-half adjusted earnings rose nearly 19%, but organic sales growth remained modest at roughly 1.2%, with Skin Health and Beauty the clearest growth driver while Self Care volumes lagged. The company also carries meaningful leverage, with total debt around $8.5 billion.
However, KVUE's recent performance is best understood through its pending acquisition. Under the agreement with Kimberly-Clark, each Kenvue share would convert into a combination of Kimberly-Clark stock plus cash, so the share price now tracks the acquirer's value closely and trades in a narrow range near the implied offer value. With shareholder and U.S. antitrust approvals complete, and a conditional European clearance secured, the transaction is expected to close in the fourth quarter of 2026 pending remaining regulatory steps. Revived litigation over Tylenol remains a key overhang.
Trending AI Robots
For traders who prefer a systematic approach to evaluating names like CL and KVUE, Tickeron's Trending AI Robots page curates a focused selection from a much larger universe of AI trading bots. Tickeron offers hundreds of automated bots that trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance record, and set of covered symbols. Because only the strategies best suited to prevailing market conditions earn a place in the curated section, the page serves as a useful filter for identifying approaches that are currently in favor rather than sifting through the full catalog. Browsing the Trending AI Robots can provide a data-driven complement to traditional fundamental comparison.
Head-to-Head Comparison
The two companies diverge most sharply in business model and growth drivers. Colgate-Palmolive is an operating company with organic growth, a 60%+ gross margin profile, and a modest but rising dividend, while Kenvue is a target in a stock-and-cash merger whose market value is now largely a function of Kimberly-Clark's share price rather than its own fundamentals. On valuation, CL commands a premium forward P/E near the low 20s, reflecting its brand strength and consistency, whereas KVUE trades at a lower multiple and offers a materially higher dividend yield.
Risk profiles also differ. Colgate-Palmolive's main threats are North American category softness, competitive intensity, and input-cost inflation. Kenvue's risks are event-driven: deal-closing timing, litigation exposure, and the leverage that would result from the combination. Sector exposure is related but not identical—both are defensive, yet Colgate-Palmolive leans toward daily-use essentials and pet nutrition, while Kenvue spans over-the-counter medicines and beauty. Sentiment reflects this: CL draws steady, low-volatility demand, while KVUE is now dominated by merger-arbitrage positioning.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely lean toward CL as the more attractive standalone candidate. Colgate-Palmolive offers more consistent trend behavior, a diversified global growth engine, strong margin expansion, and a defensive, low-beta profile that tends to hold up well in uncertain conditions. Kenvue, by contrast, is now a merger-driven situation whose price is constrained by the offer value and exposed to litigation and closing risk, leaving limited independent upside signal. That said, the verdict is probabilistic rather than definitive: KVUE's higher yield and event-driven certainty may appeal to different objectives. The relative positioning favors CL for trend consistency and stability, while KVUE remains an event-risk trade.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CL is a Buy and KVUE is a Hold.
CL in upward trend: 10-day moving average broke above 50-day moving average on October 16, 2026
The 10-day moving average for CL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 59 cases where CL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on CL as a result. In 31 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.
The Moving Average Convergence Divergence (MACD) for CL just turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 22 of 43 cases over the following month. The odds of a continued upward trend are 51%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 145 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 118 of 277 cases where CL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
Bearish Trend Analysis
The 10-day RSI Indicator for CL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 14 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CL broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (329.104) is very high in comparison to the industry average of (20.672). P/E Ratio (38.358) is within average values for comparable stocks, (16.840). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.022) settles around the average of (0.033) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.902).
Momentum Indicator for KVUE turns positive, indicating new upward trend
KVUE saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 60 similar instances where the indicator turned positive. In 37 of the 60 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for KVUE just turned positive on October 06, 2026. Looking at past instances where KVUE's MACD turned positive, the stock continued to rise in 14 of 26 cases over the following month. The odds of a continued upward trend are 54%.
KVUE moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for KVUE crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.
Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where KVUE advanced for three days, in 99 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 59 of 134 cases where KVUE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 44%.
Bearish Trend Analysis
The 10-day RSI Indicator for KVUE moved out of overbought territory on October 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 16 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 21 of 39 cases where KVUE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KVUE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
KVUE broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 28 (best 1 - 100 worst), indicating outstanding price growth. KVUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.515) is normal, around the industry mean (20.672). P/E Ratio (22.718) is within average values for comparable stocks, (16.840). Projected Growth (PEG Ratio) (1.419) is also within normal values, averaging (1.518). Dividend Yield (0.044) settles around the average of (0.033) among similar stocks. P/S Ratio (2.224) is also within normal values, averaging (1.902).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KVUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
CL | ||
|---|---|---|
OUTLOOK RATING 1..100 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 42 | |
SMR RATING 1..100 | 8 | |
PRICE GROWTH RATING 1..100 | 29 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CL | KVUE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 36% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 49% | 1 day ago 54% |
| Momentum ODDS (%) | 1 day ago 46% | 1 day ago 62% |
| MACD ODDS (%) | 1 day ago 51% | 1 day ago 54% |
| TrendWeek ODDS (%) | 1 day ago 50% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 51% | 1 day ago 47% |
| Advances ODDS (%) | 1 day ago 46% | 19 days ago 53% |
| Declines ODDS (%) | 7 days ago 47% | 7 days ago 63% |
| BollingerBands ODDS (%) | 1 day ago 41% | 1 day ago 54% |
| Aroon ODDS (%) | 1 day ago 43% | 1 day ago 44% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CL’s FA Score shows that 3 FA rating(s) are green while KVUE’s FA Score has 2 green FA rating(s).
- CL’s FA Score: 3 green, 2 red.
- KVUE’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CL’s TA Score shows that 7 TA indicator(s) are bullish while KVUE’s TA Score has 6 bullish TA indicator(s).
- CL’s TA Score: 7 bullish, 3 bearish.
- KVUE’s TA Score: 6 bullish, 4 bearish.
Price Growth
CL (@Household/Personal Care) experienced а +4.65% price change this week, while KVUE (@Household/Personal Care) price change was -0.97% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -0.77%. For the same industry, the average monthly price growth was +0.60%, and the average quarterly price growth was +7.88%.
Reported Earning Dates
CL is expected to report earnings on Jan 22, 2027.
Industries' Descriptions
@Household/Personal Care (-0.77% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
Advertisement
KVUE and
Correlation & Price change
A.I.dvisor indicates that over the last year, KVUE has been loosely correlated with UL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KVUE jumps, then UL could also see price increases.
| Ticker / NAME | Correlation To KVUE | 1D Price Change % | ||
|---|---|---|---|---|
| KVUE | 100% | N/A | ||
| UL - KVUE | 51% Loosely correlated | +1.81% | ||
| PG - KVUE | 50% Loosely correlated | +1.23% | ||
| CL - KVUE | 50% Loosely correlated | +2.25% | ||
| CLX - KVUE | 47% Loosely correlated | +2.16% | ||
| KMB - KVUE | 43% Loosely correlated | +0.29% | ||
More | ||||